- Company typePrivate
- Founded2019
- HeadquartersDijon, France
- Headcount—
- GTM typeB2C
- OfferingServices
firmographics
Firmographics- Legal name
- Centre régional de coordination des dépistages des cancers en Bourgogne-Franche-Comté (CRCDC-BFC)
- Website
- https://depistagedescancers-bfc.fr
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Ownership category
- akta.pro rank
industry classification
Industry- Product category
- Public Health / Organized Cancer Screening
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD)
Keywords
Where is headquartered
LocationHeadquarters
- HQ city
- Dijon
- HQ country
- France
- HQ region
- Europe
Offices6 records
Markets served
business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Public Health Funding: CRCDC-BFC is a government-funded public health organization. It is jointly financed by the French State (through ARS de Bourgogne-Franche-Comté), the general Health Insurance regime (Assurance Maladie), ARCMSA, and the Haute-Saône Departmental Council. The screening programs are provided free of charge to eligible populations with 100% coverage by the public health system.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Breast cancer screening (mammography) for women aged 50-74 |
| Subscription | Annual | Colorectal cancer screening (immunologic test) for men and women aged 50-74 |
| Subscription | Pay-as-you-go | Cervical cancer screening (cytology/HPV test) for women aged 25-65 |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
product offering
Product offeringCore offering
CRCDC-BFC coordinates three national organized cancer screening programs in Bourgogne-Franche-Comté: biennial mammography (with double-reading) for women aged 50-74, biennial fecal immunochemical testing for men and women aged 50-74, and cytology/HPV testing for women aged 25-65. The organization sends invitations to eligible populations, coordinates with accredited healthcare providers (radiologists, GPs, gynecologists, pharmacists), manages centralized screening data and quality assurance, and runs public awareness campaigns (Mars Bleu, Octobre Rose).
Product overview
The CRCDC-BFC is a public health organization coordinating three national organized cancer screening programs in the Bourgogne-Franche-Comté region: breast cancer screening (since 2004), colorectal cancer screening (since 2008), and cervical cancer screening (since 2019). The organization manages screening invitations, coordinates with healthcare professionals (radiologists, gastroenterologists, gynecologists), organizes second readings for mammographies, and provides public awareness campaigns including Mars Bleu (colorectal) and Octobre Rose (breast cancer) initiatives. The portfolio consists of core screening services, an ambassador awareness program, and professional training for pharmacists.
Differentiator
Problem solved
Functional benefit
Products and services
- Breast Cancer Screening Program (Dépistage du cancer du sein) Organized biennial breast cancer screening for women aged 50-74 in Bourgogne-Franche-Comté, including mammography at accredited radiologists and a second-reading system for quality assurance. 100% covered by Assurance Maladie with no advance payment.
- Colorectal Cancer Screening Program (Dépistage du cancer colorectal) Organized biennial colorectal cancer screening for men and women aged 50-74 in Bourgogne-Franche-Comté using an immunologic fecal test (FIT), with kits distributed by physicians and community pharmacists. 100% covered with no advance payment.
- Cervical Cancer Screening Program (Dépistage du cancer du col de l'utérus) Organized cervical cancer screening for women aged 25-65 in Bourgogne-Franche-Comté, combining cytology testing for ages 25-29 and HPV-HR testing for ages 30-65, performed by physicians, gynecologists and midwives. Analysis fully covered with invitation, no advance payment; consultation reimbursed at 70% (100% for CSS beneficiaries).
- Ambassador Program (Programme des ambassadeurs)
Quantifiable outcome
- Breast cancer detected early can be cured in 9 out of 10 cases (90% survival rate)
- +3 more outcomes
Companies that use
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and major.
- ARS de Bourgogne-Franche-ComtécoreThe Regional Health Agency (ARS) is the primary governmental partner overseeing public health initiatives. ARS-BFC signed the convention on July 4, 2019 establishing CRCDC-BFC and provides state funding for the organization. The agency coordinates national health policy implementation at the regional level.
- Assurance Maladie (General Health Insurance)coreThe general health insurance regime is a key co-funder of the screening programs and sends electronic invitations to eligible populations. It coordinates with CRCDC-BFC on program financing and implementation under the national convention signed in March 2022.
- Institut National du Cancer (INCa)coreThe National Cancer Institute pilots the national cancer screening programs and sets quality standards. CRCDC-BFC transmits evaluation indicators to INCa and operates under the Institute's national coordination and guidelines.
- Santé publique FrancecoreThe national public health agency receives evaluation data from CRCDC-BFC and contributes to national awareness campaigns. Works with the organization on public health messaging and data surveillance for cancer screening programs.
- URPS Pharmaciens Bourgogne-Franche-ComtémajorThe Regional Union of Health Professionals (Pharmacists) collaborates with CRCDC-BFC to organize video conference training sessions for community pharmacists on colorectal cancer screening (DOCCR). This partnership enhances pharmacists' role in distributing screening kits and educating patients.
- Accredited Radiologists NetworkcoreHundreds of radiologists across Burgundy-Franche-Comté are accredited to perform mammographies within the breast cancer screening program. These specialists have received specific training and follow quality standards set by the national program.
- Healthcare Professionals (Physicians, Gynecologists, Gastroenterologists)coreGeneral practitioners, gynecologists, gastroenterologists, and other specialists collaborate in screening implementation. They perform tests, interpret results, and refer patients to care pathways when abnormalities are detected.
- Community PharmacistsmajorUnder the national convention signed March 31, 2022, community pharmacists can distribute colorectal cancer screening kits directly to patients. They receive training and support from CRCDC-BFC in partnership with URPS.
Scale indicators2 records
Recent moves7 records
Expansion highlights4 records
competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Customer concentration
social profiles
Digital presencefinancial estimates
Financial estimateRevenue estimate
Valuation estimate
leadership team
Management profileNumber of profiles
funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about
What does do?
CRCDC-BFC coordinates three national organized cancer screening programs in Bourgogne-Franche-Comté: biennial mammography (with double-reading) for women aged 50-74, biennial fecal immunochemical testing for men and women aged 50-74, and cytology/HPV testing for women aged 25-65. The organization sends invitations to eligible populations, coordinates with accredited healthcare providers (radiologists, GPs, gynecologists, pharmacists), manages centralized screening data and quality assurance, and runs public awareness campaigns (Mars Bleu, Octobre Rose).
Is a public or private company?
is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was founded?
was founded in 2019.
Where is based?
is headquartered in Dijon, France, in the Europe region.
How does make money?
One revenue line is on record: public Health Funding.
Does have an API?
No public API is recorded for .
What industry is in?
's product category is Public Health / Organized Cancer Screening. Its primary akta.pro industry code is HLAFAKAD, Breast Imaging Centers (Mammography/Tomosynthesis). Its NAICS code is 62151 and its SIC code is 8071.